Reformulation of Leronlimab to extend lifespan in
Post# of 145407
![Avatar](/images/ProfileImages/1227900469_64555_mark.jpg)
Quote:
This study will evaluate concentrated microparticle formulations of leronlimab that are designed to last longer and be delivered through a single injection. A new version of the drug will be made in the laboratory of Diogo Magnani, Ph.D., at MassBiologics of the University of Massachusetts Medical School, and formulated using a microparticle suspension technology developed by Boston-based biotechnology firm Elektrofi, Inc.
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)